Edgar Meinl mainly focuses on Immunology, Multiple sclerosis, Antibody, Pathology and Immune system. His biological study spans a wide range of topics, including Interleukin 12 and Astrocyte. His Multiple sclerosis research includes themes of Laser capture microdissection, Inflammation, Myelin, Autoimmunity and Neuroscience.
His Antibody research includes elements of Natalizumab and Lymphocyte. His research in Pathology intersects with topics in Autoimmune encephalitis and Spinal cord. While the research belongs to areas of Immune system, Edgar Meinl spends his time largely on the problem of Receptor, intersecting his research to questions surrounding Complement system, Giant cell, Immunity, Interferon gamma and Cellular immunity.
His main research concerns Immunology, Multiple sclerosis, Antibody, Pathology and Autoantibody. His works in Antigen, Immune system, Autoimmunity, T cell and Experimental autoimmune encephalomyelitis are all subjects of inquiry into Immunology. His Immune system study which covers Receptor that intersects with Cellular differentiation.
Edgar Meinl has researched Multiple sclerosis in several fields, including Myelin, Central nervous system and Neuroscience. His Pathology study combines topics from a wide range of disciplines, such as Autoimmune encephalitis, Clinically isolated syndrome, Germinal center and Spinal cord. His Autoantibody research integrates issues from Chronic inflammatory demyelinating polyneuropathy, Epitope mapping, Acute disseminated encephalomyelitis and Guillain-Barre syndrome.
The scientist’s investigation covers issues in Immunology, Antibody, Multiple sclerosis, Myelin oligodendrocyte glycoprotein and Pathology. His research related to T cell, B cell, Autoantibody, Autoimmunity and B-cell activating factor might be considered part of Immunology. In the field of Antibody, his study on Complement system and Monoclonal overlaps with subjects such as In patient.
Edgar Meinl has included themes like Myelin, Central nervous system, Lymphocyte and CD8 in his Multiple sclerosis study. His Myelin oligodendrocyte glycoprotein research is multidisciplinary, incorporating perspectives in Epitope, Fucose and Glycan. His Pathology study combines topics from a wide range of disciplines, such as Neuromyelitis optica and Optic nerve.
Edgar Meinl spends much of his time researching Immunology, Antibody, Pathogenesis, Autoantibody and Epitope. As part of his studies on Immunology, Edgar Meinl frequently links adjacent subjects like Receptor. Within one scientific family, Edgar Meinl focuses on topics pertaining to Disease under Antibody, and may sometimes address concerns connected to Complement factor I, Monoclonal, Eculizumab, Complement system and Complement membrane attack complex.
The concepts of his Pathogenesis study are interwoven with issues in Phenotype, Subclass, Fulminant, Epitope mapping and Gene isoform. In his study, which falls under the umbrella issue of Autoantibody, Clinical significance, Chronic inflammatory demyelinating polyneuropathy and Node of Ranvier is strongly linked to Polyradiculoneuropathy. His biological study deals with issues like Outpatient clinic, which deal with fields such as Multiple sclerosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Astrocytes are active players in cerebral innate immunity
Cinthia Farina;Francesca Aloisi;Edgar Meinl.
Trends in Immunology (2007)
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
Frédéric Altare;Anne Durandy;David Lammas;Jean-François Emile.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
Ping Shen;Toralf Roch;Vicky Lampropoulou;Richard A. O’Connor.
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
Markus Krumbholz;Diethilde Theil;Tobias Derfuss;Andreas Rosenwald.
Journal of Experimental Medicine (2005)
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
Andreas Junker;Markus Krumbholz;Sylvia Eisele;Hema Mohan.
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Markus Krumbholz;Diethilde Theil;Sabine Cepok;Bernhard Hemmer.
Neurofascin as a novel target for autoantibody-mediated axonal injury
Emily K. Mathey;Tobias Derfuss;Maria K. Storch;Kieran R. Williams.
Journal of Experimental Medicine (2007)
B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.
Edgar Meinl;Markus Krumbholz;Reinhard Hohlfeld.
Annals of Neurology (2006)
Latent Herpesvirus Infection in Human Trigeminal Ganglia Causes Chronic Immune Response
Diethilde Theil;Tobias Derfuss;Igor Paripovic;Simone Herberger.
American Journal of Pathology (2003)
Preferential expression and function of Toll-like receptor 3 in human astrocytes.
Cinthia Farina;Markus Krumbholz;Thomas Giese;Gunther Hartmann.
Journal of Neuroimmunology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: